» Articles » PMID: 33912343

The Effectiveness of Mammography Surveillance After Treatment of Primary Breast Cancer: A Single Centre Retrospective Cohort Study

Overview
Publisher Wolters Kluwer
Specialty Medical Education
Date 2021 Apr 29
PMID 33912343
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: There is a little evidence that routine follow-up of patients treated for early breast cancer (BC) to detect ibsilateral breast tumour recurrence (IBTR), or contralateral breast cancer (CBC), is either effective or offers any mortality benefits. We report our experience of following patients with early BC for recurrences and new primaries in order to determine the role of mammogram surveillance.

Methods: Single centre, retrospective primary observational study was designed. Patients who had BC during year 2001-2006 were included and followed for a minimum of ten years. Patients were divided based on the modalities of detecting BC in to screen detected group and clinically detected one i.e. symptomatic BC. These two groups were compared.

Results: Total number of patients considered for analysis was 2530 (screen detected BC - 703 patients and symptomatic BC - 1827 patients). The rate of recurrence including regional and distant metastasis in screen detected BC group was 8% (57/703) and 2% (43/1827) in symptomatic one. However, the prevalence of IBTR/CBC in the whole cohort was 2% (62/2530). Mammography surveillance identified 60% (37/62) of patients who had IBTRs/CBCs.Mammography surveillance detected 85% (29/34) of all IBTRs/CBCs in the . In contrast, it picked up only 29% (8/28) in the other group (Chi squared 20.5 p < 0.005).

Conclusions: Mammography surveillance is efficient for the screen detected BC group but not for the symptomatic one. Hence, it is worth suggesting different follow-up strategies for both groups. Further studies are therefore recommended.

References
1.
Reed M . Scottish Intercollegiate Guidelines Network (SIGN) 84 -- National Clinical Guideline for the Management of Breast Cancer in Women. Clin Oncol (R Coll Radiol). 2007; 19(8):588-90. DOI: 10.1016/j.clon.2007.06.006. View

2.
Khatcheressian J, Wolff A, Smith T, Grunfeld E, Muss H, Vogel V . American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006; 24(31):5091-7. DOI: 10.1200/JCO.2006.08.8575. View

3.
Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V . Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA. 1994; 271(20):1593-7. DOI: 10.1001/jama.271.20.1593. View

4.
Lopez J, Bassett L . Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings. Radiographics. 2009; 29(1):165-76. DOI: 10.1148/rg.291085100. View

5.
Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy S . Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol. 2009; 20(9):1505-1510. DOI: 10.1093/annonc/mdp037. View